WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 28, 2007, 27(48):13161-13172; doi:10.1523/JNEUROSCI.3974-07.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoeffer, C. A.
Right arrow Articles by Rothermel, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoeffer, C. A.
Right arrow Articles by Rothermel, B. A.

 Previous Article  |  Next Article 

Neurobiology of Disease
The Down Syndrome Critical Region Protein RCAN1 Regulates Long-Term Potentiation and Memory via Inhibition of Phosphatase Signaling

Charles A. Hoeffer,1,6 Asim Dey,3 Nita Sachan,3 Helen Wong,6 Richard J. Patterson,1 John M. Shelton,3 James A. Richardson,4,5 Eric Klann,1,2,6 and Beverly A. Rothermel3

Departments of 1Molecular Physiology and Biophysics and 2Neuroscience, Baylor College of Medicine, Houston, Texas 77030, Departments of 3Internal Medicine, 4Molecular Biology, and 5Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, and 6Center for Neural Science, New York University, New York, New York 10003

Correspondence should be addressed to Eric Klann, Center for Neural Science, 4 Washington Place, Room 809, New York University, New York, NY 10003. Email: eklann{at}cns.nyu.edu

Regulator of calcineurin 1 (RCAN1/MCIP1/DSCR1) regulates the calmodulin-dependent phosphatase calcineurin. Because it is located on human chromosome 21, RCAN1 has been postulated to contribute to mental retardation in Down syndrome and has been reported to be associated with neuronal degeneration in Alzheimer's disease. The studies herein are the first to assess the role of RCAN1 in memory and synaptic plasticity by examining the behavioral and electrophysiological properties of RCAN1 knock-out mice. These mice exhibit deficits in spatial learning and memory, reduced associative cued memory, and impaired late-phase long-term potentiation (L-LTP), phenotypes similar to those of transgenic mice with increased calcineurin activity. Consistent with this, the RCAN1 knock-out mice display increased enzymatic calcineurin activity, increased abundance of a cleaved calcineurin fragment, and decreased phosphorylation of the calcineurin substrate dopamine and cAMP-regulated phosphoprotein-32. We propose a model in which RCAN1 plays a positive role in L-LTP and memory by constraining phosphatase signaling.

Key words: calcineurin; protein phosphatase; mental retardation; hippocampus; learning and memory; synaptic plasticity


Received March 13, 2007; revised Oct. 9, 2007; accepted Oct. 16, 2007.

Correspondence should be addressed to Eric Klann, Center for Neural Science, 4 Washington Place, Room 809, New York University, New York, NY 10003. Email: eklann{at}cns.nyu.edu




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
S. Mehta, H. Li, P. G. Hogan, and K. W. Cunningham
Domain Architecture of the Regulators of Calcineurin (RCANs) and Identification of a Divergent RCAN in Yeast
Mol. Cell. Biol., May 15, 2009; 29(10): 2777 - 2793.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Ermak, K. J. Hench, K. T. Chang, S. Sachdev, and K. J. A. Davies
Regulator of Calcineurin (RCAN1-1L) Is Deficient in Huntington Disease and Protective against Mutant Huntingtin Toxicity in Vitro
J. Biol. Chem., May 1, 2009; 284(18): 11845 - 11853.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Martinez-Martinez, L. Genesca, A. Rodriguez, A. Raya, E. Salichs, F. Were, M. D. Lopez-Maderuelo, J. M. Redondo, and S. de la Luna
The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators
PNAS, April 14, 2009; 106(15): 6117 - 6122.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-